Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.5411
-0.0085 (-1.55%)
At close: Jul 20, 2026, 4:00 PM EDT
0.5519
+0.0108 (2.00%)
After-hours: Jul 20, 2026, 7:13 PM EDT
Oragenics Market Cap
Oragenics has a market cap or net worth of $2.44 million as of July 20, 2026. Its market cap has increased by 144.14% in one year.
Market Cap
2.44M
Enterprise Value
-3.55M
1-Year Change
144.14%
Ranking
Category
Stock Price
$0.54
ChartMarket Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $1.60M to $2.44M, an increase of 52.59%. That is a compound annual growth rate of 1.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.44M | -26.02% |
| Dec 31, 2025 | 3.30M | -26.67% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.50% |
| Dec 31, 2009 | 27.20M | 186.32% |
| Dec 31, 2008 | 9.50M | -17.39% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.25% |
| Dec 31, 2004 | 55.30M | 3,356.25% |
| Feb 27, 2004 | 1.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 3.02M |
| Decoy Therapeutics | 2.98M |
| Clearmind Medicine | 2.88M |
| SciSparc | 2.87M |
| Onconetix | 2.81M |
| GRI Bio | 2.66M |
| Calidi Biotherapeutics | 2.31M |
| Azitra | 2.25M |